Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve Audited Financial results for quarter and year ended on 31st March 2025.
Board Meeting Intimation for Board Meeting Intimation For Approval Of Audited Financial Results For Quarter And Year Ended On 31St March 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Omkar Pharmachem Ltd. on 6ix
Story so far
Earlier from Omkar Pharmachem
- Omkar Pharmachem Ltd. Press Release Apr 11 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Omkar Pharmachem Ltd. Press Release Mar 27 2025
- Closure of Trading Window
- Omkar Pharmachem Ltd. Press Release Feb 15 2025
Later from Omkar Pharmachem
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Omkar Pharmachem Ltd. Press Release May 27 2025
- Board Meeting Outcome for Outcome Of The Board Meeting Held On 29Th May 2025 For Approval Of Audited Financial Statements For Quarter And Year Ended On March 2025
- Results- Financial Results For March 31, 2025
- Announcement under Regulation 30 (LODR)-Change in Management
Follow Omkar Pharmachem into a list and get an email when it puts out news.
Follow Omkar Pharmachem